NASDAQ NMS - GLOBAL MARKET · MNKD

+0.60% · +$0.0200 · Vol Not reported

Pre-market · updated 04:30:31 ET

MannKind Corp

Biotechnology

$3.36

Card

Relationship Map

Follow $MNKD

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $MNKD by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measured

Wed Sep 23 · last completed session · Pre-market · regular session opens 9:30 ET · MNKD

Methodology

Wed Sep 23 snapshot unavailable for MNKD. Cause unavailable.

Analyst data unavailable at compute time

MNKD

MannKind Corp

Wed Sep 23 · last completed session · Pre-market · regular session opens 9:30 ET

62/100

Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

62/ 100

Veridion Score

Upper range · MEDIUM confidence · 5 of 6 factors measured

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: MEDIUM · 5 of 6 factors measured · Wed Sep 23 · last completed session · Pre-market · regular session opens 9:30 ET

Share on X →

Veridion Score History · 90D

AI Analysis

Sovereign

Why is MNKD moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move MNKD next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Coverage building

No dated catalysts found for MNKD in the current source window. The page stays empty rather than inventing an event without a receipt.

About MannKind Corp

PHARMACEUTICAL PREPARATIONS

Listed since

2004

Employees

592

Country

MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$3.34

Last session

Day high

$3.34

Last session

Day low

$3.34

Last session

Previous close

$3.34

52W high

$6.21

-45.89% from high

52W low

$2.28

27% of range

Market cap

$1.1B

P/E

188.66×

EPS

$-0.0800

Beta

1.04

Shares out

321.5M

Avg volume

3.8M

VWAP

$3.34

Last session

Price history computed in-house

-6.15%

-19.23%

-18.84%

-36.96%

YTD

-40.74%

SMA 50 $3.92 · below

SMA 200 $4.06 · below

52W position 27%

MNKD overview

Veridion Score

Registered · 2026-09-22

5 of 6 factors measured

Latest receipt rows

No recent disclosure on file.

13F holders

None on file

Relationship mapTrace receipt-backed holders and filings around MNKD.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.

SEC Form 4 ledger

MNKD insider activity

MannKind Corp

Score

Not evaluated

Pressure

Not evaluated

Filings

Buys / sells

0 / 0

Net value

Not evaluated

Insiders

Cluster

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked

Net pressure

Not evaluated: no value-bearing Form 4 rows are loaded.

Convergence not evaluated

No value-bearing Form 4 rows are loaded, so cross-source convergence is not evaluated.

Form 4 evidence state

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in MNKD

Congress tracker Open ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for MNKD in the cached public ledger.

Federal contracts

MNKD contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for MNKD in this window.

Lobbying spend

MNKD lobbying filings, year to date.

Registered lobbying filings matched to MannKind Corp.

Not disclosed

Refresh interval: 12hSource: LDA disclosure filings

No lobbying filings on file for MNKD in this window.

Analyst ratings

Sovereign unlock shows live analyst consensus for MNKD.

Options

Sovereign unlock shows live options positioning for MNKD.

Related tickers

Cross-references from this score page.

Apprentice · 1 rail

Similar headline score

Nearest public composite scores. Factor similarity requires Sovereign.

Methodology

No related ticker met the data requirements for this rail.

Follow $MNKD

Why is MNKD moving today?

What can move MNKD next.

MNKD overview

Related filings and maps

MNKD insider activity

MNKD contract awards, year to date.

MNKD lobbying filings, year to date.

Cross-references from this score page.

What can move MNKD next.

MNKD insider activity

Cross-references from this score page.